Critical role of the coronary microvasculature in heart disease : From pathologic driving force to "innocent" bystander
© 2022 The Authors..
The coronary microvasculature is responsible for providing oxygen and nutrients to myocardial tissue. A healthy microvasculature with an intact and properly functioning endothelium accomplishes this by seemless changes in vascular tone to match supply and demand. Perturbations in the normal physiology of the microvasculature, including endothelial and/or vascular smooth muscle dysfunction, result in impaired function (vasoconstriction, antithrombotic, etc.) and structural (hypertrophic, fibrotic) abnormalities that lead to microvascular ischemia and potential organ damage. While coronary microvascular dysfunction (CMD) is the primary pathologic driving force in ischemia with non-obstructive coronary artery disease (INOCA), angina with no obstructive coronary arteries (ANOCA), and myocardial infarction with non-obstructed coronary arteries (MINOCA), it may be a bystander in many cardiac disorders which later become pathologically associated with signs and/or symptoms of myocardial ischemia. Importantly, regardless of the primary or secondary basis of CMD in the heart, it is associated with important increases in morbidity and mortality. In this review we discuss salient features pertaining to known pathophysiologic mechanisms driving CMD, the spectrum of heart diseases where it places a critical role, invasive and non-invasive diagnostic testing, management strategies, and the gaps in knowledge where future research efforts are needed.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:22 |
|---|---|
| Enthalten in: |
American heart journal plus : cardiology research and practice - 22(2022) vom: 22. Okt., Seite 100215 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Prakash, Roshni O [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
ANOCA |
|---|
| Anmerkungen: |
Date Revised 03.04.2024 published: Electronic-eCollection Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.1016/j.ahjo.2022.100215 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM37048410X |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM37048410X | ||
| 003 | DE-627 | ||
| 005 | 20240404000025.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240403s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.ahjo.2022.100215 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1363.xml |
| 035 | |a (DE-627)NLM37048410X | ||
| 035 | |a (NLM)38558907 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Prakash, Roshni O |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Critical role of the coronary microvasculature in heart disease |b From pathologic driving force to "innocent" bystander |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 03.04.2024 | ||
| 500 | |a published: Electronic-eCollection | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a © 2022 The Authors. | ||
| 520 | |a The coronary microvasculature is responsible for providing oxygen and nutrients to myocardial tissue. A healthy microvasculature with an intact and properly functioning endothelium accomplishes this by seemless changes in vascular tone to match supply and demand. Perturbations in the normal physiology of the microvasculature, including endothelial and/or vascular smooth muscle dysfunction, result in impaired function (vasoconstriction, antithrombotic, etc.) and structural (hypertrophic, fibrotic) abnormalities that lead to microvascular ischemia and potential organ damage. While coronary microvascular dysfunction (CMD) is the primary pathologic driving force in ischemia with non-obstructive coronary artery disease (INOCA), angina with no obstructive coronary arteries (ANOCA), and myocardial infarction with non-obstructed coronary arteries (MINOCA), it may be a bystander in many cardiac disorders which later become pathologically associated with signs and/or symptoms of myocardial ischemia. Importantly, regardless of the primary or secondary basis of CMD in the heart, it is associated with important increases in morbidity and mortality. In this review we discuss salient features pertaining to known pathophysiologic mechanisms driving CMD, the spectrum of heart diseases where it places a critical role, invasive and non-invasive diagnostic testing, management strategies, and the gaps in knowledge where future research efforts are needed | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a ANOCA | |
| 650 | 4 | |a Coronary microvascular dysfunction | |
| 650 | 4 | |a INOCA | |
| 650 | 4 | |a MINOCA | |
| 700 | 1 | |a Chakrala, Teja S |e verfasserin |4 aut | |
| 700 | 1 | |a Feuer, Daniel S |e verfasserin |4 aut | |
| 700 | 1 | |a Valdes, Carlos A |e verfasserin |4 aut | |
| 700 | 1 | |a Pepine, Carl J |e verfasserin |4 aut | |
| 700 | 1 | |a Keeley, Ellen C |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t American heart journal plus : cardiology research and practice |d 2021 |g 22(2022) vom: 22. Okt., Seite 100215 |w (DE-627)NLM326441123 |x 2666-6022 |7 nnns |
| 773 | 1 | 8 | |g volume:22 |g year:2022 |g day:22 |g month:10 |g pages:100215 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.ahjo.2022.100215 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 22 |j 2022 |b 22 |c 10 |h 100215 | ||